Cannabis Use Common in Older Adults
Most indicate using after age 60 years for medical purposes
Physician’s Briefing Weekly Coronavirus Roundup
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
Time to Results Faster With Point-of-Care COVID-19 Testing
Time to results significantly shorter with QIAstat-Dx Respiratory SARS-CoV-2 Panel than with PCR
Cannabinoid Use Tied to Adverse Outcomes With COPD
In older adults with COPD, cannabinoid use tied to all-cause mortality, hospitalizations
E-Cigarette Use Not Tied to Wheezing in Teens
Findings similar for e-cigarette use in the past year, 30 days, or seven days
ACS: Tranexamic Acid No Better Than Placebo After Severe Injury
Antifibrinolytic agent may lower 30-day mortality when used within one hour of injury, for severe shock
NIH Launches Trial of Antibody Drugs Against COVID-19
The phase 2 trial will assess effectiveness of monoclonal antibodies in conjunction with remdesivir
Sitagliptin May Cut Mortality in T2DM Patients With COVID-19
Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes
Lack of Knowledge Barrier to Prone Positioning Use in ARDS
Implementation strategies developed included educational outreach, learning collaborative
Alcohol Abstinence Increased Among Young Adults From 2002 to 2018
However, increase seen in marijuana use, co-use of alcohol and marijuana
